Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor

被引：0
|
作者：
Rink, Lori
Skorobogatko, Yuliya
Kossenkov, Andrew
Belinsky, Martin
Pajak, Thomas
von Mehren, Margaret
Ochs, Michael
Eisenberg, Burton
Godwin, Andrew
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA
[3] Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD USA
[4] Dartmouth Hitchcock Med Ctr, Norris Cotton Canc Ctr, Lebanon, NH 03766 USA
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3844
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Central nervous system metastases from imatinib mesylate resistant gastrointestinal stromal tumor
    Gerin, Fethullah
    Baloglu, Orkun
    Morgan, Jeffrey A.
    Kesari, Santosh
    JOURNAL OF NEURO-ONCOLOGY, 2007, 82 (02) : 227 - 228
  • [42] Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor
    Pessetto, Ziyan Y.
    Ma, Yan
    Hirst, Jeff J.
    von Mehren, Margaret
    Weir, Scott J.
    Godwin, Andrew K.
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (10) : 2276 - 2287
  • [43] A metastatic case of gastrointestinal stromal tumor (GIST) treated with imatinib mesylate (Glivec®) in Mali
    Diallo, D. A.
    Ly, M.
    Diallo, G.
    Dembele, A. K.
    Toure, M.
    Toure, B. A.
    Kone, A.
    Sidibe, S.
    Dembele, M.
    Traore, C.
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2011, 35 (10) : 675 - 677
  • [44] Imatinib mesylate activates IGFBP3 expression in gastrointestinal stromal tumors.
    Dupart, J
    Trent, JC
    Cohen, P
    Zhang, W
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8987S - 8987S
  • [45] Gastrointestinal stromal tumor: New nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate
    Shankar, S
    vanSonnenberg, E
    Desai, J
    DiPiro, PJ
    Van den Abbeele, A
    Demetri, GD
    RADIOLOGY, 2005, 235 (03) : 892 - 898
  • [46] Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate
    Rausch, Jessica L.
    Boichuk, Sergei
    Ali, Areej A.
    Patil, Sneha S.
    Liu, Lijun
    Lee, Donna M.
    Brown, Matthew F.
    Makielski, Kathleen R.
    Liu, Ying
    Taguchi, Takahiro
    Kuan, Shih-Fan
    Duensing, Anette
    ONCOTARGET, 2017, 8 (03) : 4471 - 4483
  • [47] Complete Pathological Response in Advanced Extra-gastrointestinal Stromal Tumor After Imatinib Mesylate Therapy: A Case Report
    Rediti, Mattia
    Pellegrini, Elisa
    Molinara, Elena
    Cerullo, Carmine
    Fonte, Carla
    Lunghi, Alice
    Iori, Alice
    Neri, Bruno
    ANTICANCER RESEARCH, 2014, 34 (02) : 905 - 907
  • [48] Pathologic complete response confirmed by surgical resection for liver metastases of gastrointestinal stromal tumor after treatment with imatinib mesylate
    Seiji Suzuki
    Koji Sasajima
    Masayuki Miyamoto
    Hidehiro Watanabe
    Tadashi Yokoyama
    Hiroshi Maruyama
    Takeshi Matsutani
    Masaru Hosone
    Shotaro Maeda
    Takashi Tajiri
    World Journal of Gastroenterology, 2008, (23) : 3763 - 3767
  • [49] Gene expression signature may predict imatinib mesylate response
    不详
    PHARMACOGENOMICS, 2009, 10 (07) : 1129 - 1129
  • [50] Dramatic response of a gastrointestinal stromal tumor to neadjuvant imatinib therapy
    Shohrat Annaberdyev
    Joseph Gibbons
    Jeffrey M Hardacre
    World Journal of Surgical Oncology, 7
12345